TMEM100 and hepatocellular carcinoma: ZFPM2-AS1 and MIR210HG may disrupt the interaction between hsa-miR-372 and TMEM100 to promote the development of HCC, but the function of hsa-miR-372 and TMEM100 in HCC has not been reported, and thus further experiments are needed to confirm this hypothesis.